Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective COX-2 inhibition and neuroinflammation in Parkinson's disease
2007-001206-24Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of celecoxib in Parkinson's disease (PD), sponsored by University Medical Center Groningen. Primary endpoint: [11C]-PK11195 Binding Potential change. Started Aug 2007; status: active.
02
Drugs
celecoxib
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-001206-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001206-24.